This webinar covers the implementation of the Byosphere Enterprise Platform in mass spectrometry data processing and its impact on biopharmaceutical development. Anna Gal, a mass spectrometry officer at Ichnos Sciences, introduces the company’s pipeline for producing specific and multi-specific antibodies, focusing on their role in cancer treatment. She outlines her team’s support for drug product and analytical development through mass spectrometry, describing the comprehensive workflow from discovery to GMP manufacturing. Anna emphasizes the challenges of developing multi-specific antibodies, particularly product heterogeneity and instability, and explains how their proprietary platform addresses these issues through novel engineering approaches.

The presentation highlights the benefits of automating data processing with Byosphere, which significantly enhances efficiency and data integrity. Anna explains the bottlenecks encountered with traditional methods, such as limited data processing capacity and cumbersome file management, and contrasts these with the streamlined, cloud-based workflow enabled by Byosphere. The automation of data transfer and the ability to launch multiple jobs in parallel have sped up processes and improved traceability.